Source: HalifaxProj(inhibit) |
Type: |
Interleukin-6 (IL-6) is a cytokine that plays a significant role in inflammation and the immune response. It is produced by various cell types, including T cells, B cells, macrophages, and fibroblasts. IL-6 can promote tumor cell proliferation and survival. Many cancer cells produce IL-6, which can create an autocrine loop that supports their growth. |
2326- | 2DG, | Caloric Restriction Mimetic 2-Deoxyglucose Alleviated Inflammatory Lung Injury via Suppressing Nuclear Pyruvate Kinase M2–Signal Transducer and Activator of Transcription 3 Pathway |
- | in-vivo, | Nor, | NA |
232- | AL, | A Single Meal Containing Raw, Crushed Garlic Influences Expression of Immunity- and Cancer-Related Genes in Whole Blood of Humans |
- | Human, | Nor, | NA |
2660- | AL, | Allicin: A review of its important pharmacological activities |
- | Review, | AD, | NA | - | Review, | Var, | NA | - | Review, | Park, | NA | - | Review, | Stroke, | NA |
2661- | AL, | Allicin alleviates traumatic brain injury-induced neuroinflammation by enhancing PKC-δ-mediated mitophagy |
- | in-vivo, | Nor, | NA |
297- | ALA, | Insights on the Use of α-Lipoic Acid for Therapeutic Purposes |
- | Review, | BC, | SkBr3 | - | Review, | neuroblastoma, | SK-N-SH | - | Review, | AD, | NA |
3449- | ALA, | Alpha-Lipoic Acid Downregulates IL-1β and IL-6 by DNA Hypermethylation in SK-N-BE Neuroblastoma Cells |
- | in-vitro, | AD, | SK-N-BE |
3456- | ALA, | Renal-Protective Roles of Lipoic Acid in Kidney Disease |
- | Review, | NA, | NA |
3549- | ALA, | Important roles of linoleic acid and α-linolenic acid in regulating cognitive impairment and neuropsychiatric issues in metabolic-related dementia |
- | Review, | AD, | NA |
3550- | ALA, | Mitochondrial Dysfunction and Alpha-Lipoic Acid: Beneficial or Harmful in Alzheimer's Disease? |
- | Review, | AD, | NA |
1253- | aLinA, | The Antitumor Effects of α-Linolenic Acid |
- | Review, | NA, | NA |
1159- | And, | Andrographolide, an Anti-Inflammatory Multitarget Drug: All Roads Lead to Cellular Metabolism |
- | Review, | NA, | NA |
1146- | AP, | Potential use of nanoformulated ascorbyl palmitate as a promising anticancer agent: First comparative assessment between nano and free forms |
- | in-vivo, | Nor, | NA |
2639- | Api, | Plant flavone apigenin: An emerging anticancer agent |
- | Review, | Var, | NA |
1543- | Api, | Therapeutical properties of apigenin: a review on the experimental evidence and basic mechanisms |
- | Review, | NA, | NA |
1545- | Api, | The Potential Role of Apigenin in Cancer Prevention and Treatment |
- | Review, | NA, | NA |
3665- | ART/DHA, | Artemisinin B Improves Learning and Memory Impairment in AD Dementia Mice by Suppressing Neuroinflammation |
- | Review, | AD, | NA |
3667- | ART/DHA, | Artemisinin improves neurocognitive deficits associated with sepsis by activating the AMPK axis in microglia |
- | Review, | Sepsis, | NA |
4278- | ART/DHA, | Artemisinin Ameliorates the Neurotoxic Effect of 3-Nitropropionic Acid: A Possible Involvement of the ERK/BDNF/Nrf2/HO-1 Signaling Pathway |
- | in-vivo, | NA, | NA |
1074- | ART/DHA, | Artemisinin attenuates lipopolysaccharide-stimulated proinflammatory responses by inhibiting NF-κB pathway in microglia cells |
- | in-vitro, | Nor, | BV2 |
556- | ART/DHA, | Artemisinins as a novel anti-cancer therapy: Targeting a global cancer pandemic through drug repurposing |
- | Review, | NA, | NA |
565- | ART/DHA, | Artesunate as an Anti-Cancer Agent Targets Stat-3 and Favorably Suppresses Hepatocellular Carcinoma |
1177- | Ash, | Withaferin A downregulates COX-2/NF-κB signaling and modulates MMP-2/9 in experimental endometriosis |
- | in-vivo, | EC, | NA |
4303- | Ash, | Ashwagandha (Withania somnifera)—Current Research on the Health-Promoting Activities: A Narrative Review |
- | Review, | AD, | NA |
3685- | Ash, | Withania somnifera as a Potential Anxiolytic and Anti-inflammatory Candidate Against Systemic Lipopolysaccharide-Induced Neuroinflammation |
- | in-vivo, | NA, | NA |
3166- | Ash, | Exploring the Multifaceted Therapeutic Potential of Withaferin A and Its Derivatives |
- | Review, | Var, | NA |
1522- | Ba, | Baicalein reduces lipopolysaccharide-induced inflammation via suppressing JAK/STATs activation and ROS production |
- | in-vitro, | Nor, | RAW264.7 |
2605- | Ba, | BA, | Potential therapeutic effects of baicalin and baicalein |
- | Review, | Var, | NA | - | Review, | Stroke, | NA | - | Review, | IBD, | NA | - | Review, | Arthritis, | NA | - | Review, | AD, | NA | - | Review, | Park, | NA |
2610- | Ba, | Hepatoprotective effects of baicalein against CCl4-induced acute liver injury in mice |
- | in-vivo, | Nor, | NA |
2627- | Ba, | Cisplatin, | Baicalein, a Bioflavonoid, Prevents Cisplatin-Induced Acute Kidney Injury by Up-Regulating Antioxidant Defenses and Down-Regulating the MAPKs and NF-κB Pathways |
2617- | Ba, | Potential of baicalein in the prevention and treatment of cancer: A scientometric analyses based review |
- | Review, | Var, | NA |
2290- | Ba, | Research Progress of Scutellaria baicalensis in the Treatment of Gastrointestinal Cancer |
- | Review, | GI, | NA |
4276- | BA, | Baicalin Attenuates Oxygen–Glucose Deprivation/Reoxygenation–Induced Injury by Modulating the BDNF-TrkB/PI3K/Akt and MAPK/Erk1/2 Signaling Axes in Neuron–Astrocyte Cocultures |
- | in-vivo, | Stroke, | NA |
4274- | BBR, | Berberine exerts antidepressant effects in vivo and in vitro through the PI3K/AKT/CREB/BDNF signaling pathway |
- | in-vivo, | NA, | NA |
1092- | BBR, | Berberine as a Potential Anticancer Agent: A Comprehensive Review |
- | Review, | NA, | NA |
2713- | BBR, | Berberine improved the microbiota in lung tissue of colon cancer and reversed the bronchial epithelial cell changes caused by cancer cells |
- | in-vitro, | Nor, | BEAS-2B |
2674- | BBR, | Berberine: A novel therapeutic strategy for cancer |
- | Review, | Var, | NA | - | Review, | IBD, | NA |
2677- | BBR, | Liposome-Encapsulated Berberine Alleviates Liver Injury in Type 2 Diabetes via Promoting AMPK/mTOR-Mediated Autophagy and Reducing ER Stress: Morphometric and Immunohistochemical Scoring |
- | in-vivo, | Diabetic, | NA |
2686- | BBR, | Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs |
- | Review, | Nor, | NA |
2749- | BetA, | Anti-Inflammatory Activities of Betulinic Acid: A Review |
- | Review, | Nor, | NA |
2725- | BetA, | Betulinic acid protects against renal damage by attenuation of oxidative stress and inflammation via Nrf2 signaling pathway in T-2 toxin-induced mice |
- | in-vivo, | Nor, | NA |
3517- | Bor, | Se, | The protective effects of selenium and boron on cyclophosphamide-induced hepatic oxidative stress, inflammation, and apoptosis in rats |
- | in-vivo, | Nor, | NA |
3516- | Bor, | Boron in wound healing: a comprehensive investigation of its diverse mechanisms |
- | Review, | Wounds, | NA |
3520- | Bor, | Effect of boron element on photoaging in rats |
- | in-vivo, | NA, | NA |
726- | Bor, | Redox Mechanisms Underlying the Cytostatic Effects of Boric Acid on Cancer Cells—An Issue Still Open |
- | Review, | NA, | NA |
743- | Bor, | Boric Acid (Boron) Attenuates AOM-Induced Colorectal Cancer in Rats by Augmentation of Apoptotic and Antioxidant Mechanisms |
- | in-vitro, | CRC, | NA |
699- | Bor, | Boric Acid Alleviates Gastric Ulcer by Regulating Oxidative Stress and Inflammation-Related Multiple Signaling Pathways |
- | in-vivo, | NA, | NA |
2776- | Bos, | Anti-inflammatory and anti-cancer activities of frankincense: Targets, treatments and toxicities |
- | Review, | Var, | NA |
2775- | Bos, | The journey of boswellic acids from synthesis to pharmacological activities |
- | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | PSA, | NA |
2772- | Bos, | Mechanistic role of boswellic acids in Alzheimer’s disease: Emphasis on anti-inflammatory properties |
- | Review, | AD, | NA |
2768- | Bos, | Boswellic acids as promising agents for the management of brain diseases |
- | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Park, | NA |
1011- | CA, | Dihydrocaffeic acid improves IL-1β-induced inflammation and cartilage degradation via inhibiting NF-κB and MAPK signalling pathways |
- | in-vivo, | NA, | NA |
1652- | CA, | Caffeic Acid and Diseases—Mechanisms of Action |
- | Review, | Var, | NA |
3854- | CAP, | Capsaicin consumption reduces brain amyloid-beta generation and attenuates Alzheimer’s disease-type pathology and cognitive deficits in APP/PS1 mice |
- | in-vivo, | AD, | NA |
3869- | Carno, | Carnosine, Small but Mighty—Prospect of Use as Functional Ingredient for Functional Food Formulation |
- | Review, | AD, | NA | - | Review, | Stroke, | NA |
2392- | Cela, | The role of natural products targeting macrophage polarization in sepsis-induced lung injury |
- | Review, | Sepsis, | NA |
2393- | Cela, | Celastrol mitigates inflammation in sepsis by inhibiting the PKM2-dependent Warburg effect |
- | in-vivo, | Sepsis, | NA | - | in-vitro, | Nor, | RAW264.7 |
2782- | CHr, | Broad-Spectrum Preclinical Antitumor Activity of Chrysin: Current Trends and Future Perspectives |
- | Review, | Var, | NA | - | Review, | Stroke, | NA | - | Review, | Park, | NA |
2785- | CHr, | Emerging cellular and molecular mechanisms underlying anticancer indications of chrysin |
- | Review, | Var, | NA |
4257- | CoQ10, | Dietary intake of coenzyme Q10 reduces oxidative stress in patients with acute ischemic stroke: a double-blind, randomized placebo-controlled study |
- | Trial, | Stroke, | NA |
3994- | CoQ10, | Se, | Coenzyme Q10 Supplementation in Aging and Disease |
- | Review, | AD, | NA | - | Review, | Park, | NA |
1809- | CUR, | Oxy, | Long-term stabilisation of myeloma with curcumin |
- | Case Report, | Melanoma, | NA |
1418- | CUR, | Potential complementary and/or synergistic effects of curcumin and boswellic acids for management of osteoarthritis |
- | Review, | Arthritis, | NA |
140- | CUR, | Curcumin inhibits cancer-associated fibroblast-driven prostate cancer invasion through MAOA/mTOR/HIF-1α signaling |
- | in-vitro, | Pca, | PC3 |
13- | CUR, | Role of curcumin in regulating p53 in breast cancer: an overview of the mechanism of action |
- | Review, | BC, | NA |
15- | CUR, | UA, | Effects of curcumin and ursolic acid in prostate cancer: A systematic review |
465- | CUR, | Curcumin inhibits the growth of liver cancer by impairing myeloid-derived suppressor cells in murine tumor tissues |
- | vitro+vivo, | Liver, | HepG2 | - | vitro+vivo, | Liver, | HUH7 | - | vitro+vivo, | Liver, | MHCC-97H |
2818- | CUR, | Novel Insight to Neuroprotective Potential of Curcumin: A Mechanistic Review of Possible Involvement of Mitochondrial Biogenesis and PI3/Akt/ GSK3 or PI3/Akt/CREB/BDNF Signaling Pathways |
- | Review, | AD, | NA |
2688- | CUR, | Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs |
- | Review, | Var, | NA | - | Review, | AD, | NA |
3794- | CUR, | Curcumin hybrid molecules for the treatment of Alzheimer's disease: Structure and pharmacological activities |
- | Review, | AD, | NA |
3582- | CUR, | PI, | Therapeutic and Preventive Effects of Piperine and its Combination with Curcumin as a Bioenhancer Against Aluminum-Induced Damage in the Astrocyte Cells |
3588- | CUR, | The effect of curcumin on cognition in Alzheimer’s disease and healthy aging: A systematic review of pre-clinical and clinical studies |
- | Review, | AD, | NA |
1085- | DHA, | EPA, | DHA and EPA Down-regulate COX-2 Expression through Suppression of NF-kappaB Activity in LPS-treated Human Umbilical Vein Endothelial Cells |
- | in-vitro, | Nor, | HUVECs |
3708- | dietSTF, | Fasting as a Therapy in Neurological Disease |
1607- | EA, | Exploring the Potential of Ellagic Acid in Gastrointestinal Cancer Prevention: Recent Advances and Future Directions |
- | Review, | GC, | NA |
1620- | EA, | Rad, | Radiosensitizing effect of ellagic acid on growth of Hepatocellular carcinoma cells: an in vitro study |
- | in-vitro, | Liver, | HepG2 |
1503- | EGCG, | Epigenetic targets of bioactive dietary components for cancer prevention and therapy |
- | Review, | NA, | NA |
- | in-vitro, | GBM, | U87MG |
3594- | EGCG, | Epigallocatechin-3-gallate inhibits secretion of TNF-alpha, IL-6 and IL-8 through the attenuation of ERK and NF-kappaB in HMC-1 cells |
- | in-vitro, | AD, | HMC1 |
3201- | EGCG, | Epigallocatechin Gallate (EGCG): Pharmacological Properties, Biological Activities and Therapeutic Potential |
- | Review, | NA, | NA |
3233- | EGCG, | Epigallocatechin gallate inhibits HeLa cells by modulation of epigenetics and signaling pathways |
- | in-vitro, | Cerv, | HeLa |
3227- | EGCG, | Epigallocatechin-3-gallate treatment to promote neuroprotection and functional recovery after nervous system injury |
- | NA, | Nor, | NA |
3225- | EGCG, | Epigallocatechin‐3‐Gallate Ameliorates Diabetic Kidney Disease by Inhibiting the TXNIP/NLRP3/IL‐1β Signaling Pathway |
- | in-vitro, | Nor, | NA | - | in-vivo, | Nor, | NA |
3714- | FA, | Recent Advances in the Neuroprotective Properties of Ferulic Acid in Alzheimer's Disease: A Narrative Review |
- | Review, | AD, | NA |
2861- | FIS, | The neuroprotective effects of fisetin, a natural flavonoid in neurodegenerative diseases: Focus on the role of oxidative stress |
- | Review, | Nor, | NA | - | Review, | Stroke, | NA | - | Review, | Park, | NA |
2841- | FIS, | Fisetin, an Anti-Inflammatory Agent, Overcomes Radioresistance by Activating the PERK-ATF4-CHOP Axis in Liver Cancer |
- | in-vitro, | Nor, | RAW264.7 | - | in-vitro, | Liver, | HepG2 | - | in-vitro, | Liver, | Hep3B | - | in-vitro, | Liver, | HUH7 |
2843- | FIS, | Fisetin and Quercetin: Promising Flavonoids with Chemopreventive Potential |
- | Review, | Var, | NA |
805- | GAR, | Cisplatin, | PacT, | Garcinol Exhibits Anti-Neoplastic Effects by Targeting Diverse Oncogenic Factors in Tumor Cells |
- | Review, | NA, | NA |
4003- | Gins, | Neuroprotective Potentials of Panax Ginseng Against Alzheimer's Disease: A Review of Preclinical and Clinical Evidences |
- | Review, | adrenal, | NA |
2503- | H2, | Brain Metastases Completely Disappear in Non-Small Cell Lung Cancer Using Hydrogen Gas Inhalation: A Case Report |
- | Case Report, | Lung, | NA |
2521- | H2, | Oxyhydrogen Gas: A Promising Therapeutic Approach for Lung, Breast and Colorectal Cancer |
- | Review, | CRC, | NA | - | Review, | Lung, | NA | - | Review, | BC, | NA |
2514- | H2, | Hydrogen: A Novel Option in Human Disease Treatment |
- | Review, | NA, | NA |
2516- | H2, | Hydrogen Gas in Cancer Treatment |
- | Review, | Var, | NA |
2530- | H2, | Improvement of psoriasis-associated arthritis and skin lesions by treatment with molecular hydrogen: A report of three cases |
- | Case Report, | PSA, | NA |
3787- | H2, | Hydrogen, a Novel Therapeutic Molecule, Regulates Oxidative Stress, Inflammation, and Apoptosis |
- | Review, | AD, | NA |
3773- | H2, | Role and mechanism of molecular hydrogen in the treatment of Parkinson’s diseases |
- | Review, | Park, | NA |
3772- | H2, | Therapeutic potential of hydrogen-rich water in zebrafish model of Alzheimer’s disease: targeting oxidative stress, inflammation, and the gut-brain axis |
- | in-vivo, | AD, | NA |
3770- | H2, | Role of Molecular Hydrogen in Ageing and Ageing-Related Diseases |
- | Review, | AD, | NA | - | Review, | Park, | NA |
3766- | H2, | The role of hydrogen in Alzheimer′s disease |
- | Review, | AD, | NA |
3768- | H2, | Effects of Hydrogen Gas Inhalation on Community-Dwelling Adults of Various Ages: A Single-Arm, Open-Label, Prospective Clinical Trial |
- | Trial, | AD, | NA |
4346- | H2, | Medical Application of Hydrogen in Hematological Diseases |
- | Review, | NA, | NA |
4307- | H2, | Hydrogen Gas Attenuates Toxic Metabolites and Oxidative Stress-Mediated Signaling to Inhibit Neurodegeneration and Enhance Memory in Alzheimer’s Disease Models |
- | in-vivo, | AD, | NA |
1637- | HCA, | OLST, | Orlistat and Hydroxycitrate Ameliorate Colon Cancer in Rats: The Impact of Inflammatory Mediators |
- | in-vivo, | Colon, | NA |
2885- | HNK, | Honokiol: a novel natural agent for cancer prevention and therapy |
2868- | HNK, | Honokiol: A review of its pharmacological potential and therapeutic insights |
- | Review, | Var, | NA | - | Review, | Sepsis, | NA |
2871- | HNK, | Antihyperalgesic Properties of Honokiol in Inflammatory Pain Models by Targeting of NF-κB and Nrf2 Signaling |
- | in-vivo, | Nor, | NA |
4007- | K+, | The increased potassium intake improves cognitive performance and attenuates histopathological markers in a model of Alzheimer's disease |
- | in-vivo, | AD, | NA |
2916- | LT, | Antioxidative and Anticancer Potential of Luteolin: A Comprehensive Approach Against Wide Range of Human Malignancies |
- | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Park, | NA |
2919- | LT, | Luteolin as a potential therapeutic candidate for lung cancer: Emerging preclinical evidence |
- | Review, | Var, | NA |
2921- | LT, | Luteolin as a potential hepatoprotective drug: Molecular mechanisms and treatment strategies |
- | Review, | Nor, | NA |
2911- | LT, | Luteolin targets MKK4 to attenuate particulate matter-induced MMP-1 and inflammation in human keratinocytes |
- | in-vitro, | Nor, | HaCaT |
4292- | LT, | Luteolin for neurodegenerative diseases: a review |
- | Review, | AD, | NA | - | Review, | Park, | NA | - | Review, | MS, | NA | - | Review, | Stroke, | NA |
3528- | Lyco, | The Importance of Antioxidant Activity for the Health-Promoting Effect of Lycopene |
- | Review, | Nor, | NA | - | Review, | AD, | NA | - | Review, | Park, | NA |
3531- | Lyco, | Lycopene attenuates the inflammation and apoptosis in aristolochic acid nephropathy by targeting the Nrf2 antioxidant system |
- | in-vivo, | Nor, | NA |
3277- | Lyco, | Recent trends and advances in the epidemiology, synergism, and delivery system of lycopene as an anti-cancer agent |
- | Review, | Var, | NA |
3278- | Lyco, | Anti-inflammatory effect of lycopene in SW480 human colorectal cancer cells |
- | in-vitro, | Colon, | SW480 |
3264- | Lyco, | Pharmacological potentials of lycopene against aging and aging‐related disorders: A review |
- | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Stroke, | NA |
1708- | Lyco, | The Anti-Cancer Activity of Lycopene: A Systematic Review of Human and Animal Studies |
- | Review, | Var, | NA |
1782- | MEL, | Melatonin in Cancer Treatment: Current Knowledge and Future Opportunities |
- | Review, | Var, | NA |
1779- | MEL, | Therapeutic Potential of Melatonin Counteracting Chemotherapy-Induced Toxicity in Breast Cancer Patients: A Systematic Review |
- | Review, | BC, | NA |
2246- | MF, | The Use of Pulsed Electromagnetic Field to Modulate Inflammation and Improve Tissue Regeneration: A Review |
- | in-vitro, | Nor, | NA |
3741- | MF, | Promising application of Pulsed Electromagnetic Fields (PEMFs) in musculoskeletal disorders |
- | Review, | NA, | NA |
3536- | MF, | Targeting Mesenchymal Stromal Cells/Pericytes (MSCs) With Pulsed Electromagnetic Field (PEMF) Has the Potential to Treat Rheumatoid Arthritis |
- | Review, | Arthritis, | NA | - | Review, | Stroke, | NA |
3474- | MF, | Pulsed electromagnetic fields potentiate the paracrine function of mesenchymal stem cells for cartilage regeneration |
- | in-vitro, | Nor, | NA |
3468- | MF, | An integrative review of pulsed electromagnetic field therapy (PEMF) and wound healing |
- | Review, | NA, | NA |
3470- | MF, | Pulsed electromagnetic fields inhibit IL-37 to alleviate CD8+ T cell dysfunction and suppress cervical cancer progression |
- | in-vitro, | Cerv, | HeLa |
204- | MFrot, | MF, | Rotating magnetic field improved cognitive and memory impairments in a sporadic ad model of mice by regulating microglial polarization |
- | in-vivo, | AD, | NA |
221- | MFrot, | MF, | Low Frequency Magnetic Fields Enhance Antitumor Immune Response against Mouse H22 Hepatocellular Carcinoma |
- | in-vivo, | Liver, | NA |
3847- | MSM, | Methylsulfonylmethane: Applications and Safety of a Novel Dietary Supplement |
- | Review, | Arthritis, | NA |
1806- | NarG, | Naringin: Nanotechnological Strategies for Potential Pharmaceutical Applications |
- | Review, | NA, | NA |
2381- | PBG, | Chinese Poplar Propolis Inhibits MDA-MB-231 Cell Proliferation in an Inflammatory Microenvironment by Targeting Enzymes of the Glycolytic Pathway |
- | in-vitro, | BC, | MDA-MB-231 |
1663- | PBG, | Propolis and Their Active Constituents for Chronic Diseases |
- | Review, | Var, | NA |
1662- | PBG, | The immunomodulatory and anticancer properties of propolis |
- | Review, | Var, | NA |
1682- | PBG, | Honey, Propolis, and Royal Jelly: A Comprehensive Review of Their Biological Actions and Health Benefits |
- | Review, | Var, | NA |
1680- | PBG, | Protection against Ultraviolet A-Induced Skin Apoptosis and Carcinogenesis through the Oxidative Stress Reduction Effects of N-(4-bromophenethyl) Caffeamide, a Propolis Derivative |
- | in-vitro, | Nor, | HS68 |
1231- | PBG, | Caffeic acid phenethyl ester inhibits MDA-MB-231 cell proliferation in inflammatory microenvironment by suppressing glycolysis and lipid metabolism |
- | in-vitro, | BC, | MDA-MB-231 |
3249- | PBG, | Can Propolis Be a Useful Adjuvant in Brain and Neurological Disorders and Injuries? A Systematic Scoping Review of the Latest Experimental Evidence |
- | Review, | Var, | NA |
3257- | PBG, | The Potential Use of Propolis as a Primary or an Adjunctive Therapy in Respiratory Tract-Related Diseases and Disorders: A Systematic Scoping Review |
- | Review, | Var, | NA |
1258- | PI, | Piperlongumine Alleviates Mouse Colitis and Colitis-Associated Colorectal Cancer |
- | in-vivo, | CRC, | NA |
3589- | PI, | Anti-inflammatory and antiarthritic effects of piperine in human interleukin 1β-stimulated fibroblast-like synoviocytes and in rat arthritis models |
- | in-vivo, | Arthritis, | NA |
1165- | PI, | Piperine inhibits IL-1β-induced IL-6 expression by suppressing p38 MAPK and STAT3 activation in gastric cancer cells |
- | in-vitro, | GC, | TMK-1 |
1938- | PL, | Piperlongumine regulates epigenetic modulation and alleviates psoriasis-like skin inflammation via inhibition of hyperproliferation and inflammation |
- | Study, | PSA, | NA | - | in-vivo, | NA, | NA |
2948- | PL, | The promising potential of piperlongumine as an emerging therapeutics for cancer |
- | Review, | Var, | NA |
2946- | PL, | Piperlongumine, a potent anticancer phytotherapeutic: Perspectives on contemporary status and future possibilities as an anticancer agent |
- | Review, | Var, | NA |
2973- | PL, | The Natural Alkaloid Piperlongumine Inhibits Metastatic Activity and Epithelial-to-Mesenchymal Transition of Triple-Negative Mammary Carcinoma Cells |
- | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | 4T1 |
3917- | PS, | Phosphatidylserine, inflammation, and central nervous system diseases |
- | Review, | AD, | NA | - | Review, | Park, | NA | - | Review, | Stroke, | NA |
3931- | PTS, | Pterostilbene Protects against Osteoarthritis through NLRP3 Inflammasome Inactivation and Improves Gut Microbiota as Evidenced by In Vivo and In Vitro Studies |
- | in-vivo, | Arthritis, | NA |
3924- | PTS, | Effect of resveratrol and pterostilbene on aging and longevity |
- | Review, | AD, | NA | - | Review, | Stroke, | NA |
3918- | PTS, | Pterostilbene inhibits amyloid-β-induced neuroinflammation in a microglia cell line by inactivating the NLRP3/caspase-1 inflammasome pathway |
- | in-vitro, | AD, | BV2 |
2338- | QC, | Quercetin: A Flavonoid with Potential for Treating Acute Lung Injury |
- | Review, | Nor, | NA |
3354- | QC, | Quercetin: Its Main Pharmacological Activity and Potential Application in Clinical Medicine |
- | Review, | Var, | NA |
3347- | QC, | Recent Advances in Potential Health Benefits of Quercetin |
- | Review, | Var, | NA | - | Review, | AD, | NA |
3380- | QC, | Quercetin as a JAK–STAT inhibitor: a potential role in solid tumors and neurodegenerative diseases |
- | Review, | Var, | NA | - | Review, | Park, | NA | - | Review, | AD, | NA |
3369- | QC, | Pharmacological basis and new insights of quercetin action in respect to its anti-cancer effects |
- | Review, | Pca, | NA |
3368- | QC, | The potential anti-cancer effects of quercetin on blood, prostate and lung cancers: An update |
- | Review, | Var, | NA |
4296- | QC, | A Flavonoid on the Brain: Quercetin as a Potential Therapeutic Agent in Central Nervous System Disorders |
- | Review, | AD, | NA |
3534- | QC, | Lyco, | Synergistic protection of quercetin and lycopene against oxidative stress via SIRT1-Nox4-ROS axis in HUVEC cells |
- | in-vitro, | Nor, | HUVECs |
3603- | QC, | Mechanism of quercetin therapeutic targets for Alzheimer disease and type 2 diabetes mellitus |
- | Review, | AD, | NA | - | Review, | Diabetic, | NA |
3606- | QC, | The Effect of Quercetin on Inflammatory Factors and Clinical Symptoms in Women with Rheumatoid Arthritis: A Double-Blind, Randomized Controlled Trial |
- | Trial, | Arthritis, | NA |
39- | QC, | A Comprehensive Analysis and Anti-Cancer Activities of Quercetin in ROS-Mediated Cancer and Cancer Stem Cells |
- | Analysis, | NA, | NA |
916- | QC, | Quercetin and cancer: new insights into its therapeutic effects on ovarian cancer cells |
- | Review, | Ovarian, | NA |
923- | QC, | Quercetin as an innovative therapeutic tool for cancer chemoprevention: Molecular mechanisms and implications in human health |
- | Review, | Var, | NA |
910- | QC, | The Anti-Cancer Effect of Quercetin: Molecular Implications in Cancer Metabolism |
3072- | RES, | Resveratrol ameliorates glioblastoma inflammatory response by reducing NLRP3 inflammasome activation through inhibition of the JAK2/STAT3 pathway |
- | in-vitro, | GBM, | LN229 | - | in-vitro, | GBM, | U87MG |
3076- | RES, | Resveratrol for targeting the tumor microenvironment and its interactions with cancer cells |
- | Review, | Var, | NA |
3079- | RES, | Therapeutic role of resveratrol against hepatocellular carcinoma: A review on its molecular mechanisms of action |
- | Review, | Var, | NA |
3055- | RES, | Resveratrol and Tumor Microenvironment: Mechanistic Basis and Therapeutic Targets |
- | Review, | Var, | NA |
3082- | RES, | Resveratrol Ameliorates the Malignant Progression of Pancreatic Cancer by Inhibiting Hypoxia-induced Pancreatic Stellate Cell Activation |
- | in-vitro, | PC, | PANC1 | - | in-vitro, | PC, | MIA PaCa-2 | - | in-vivo, | NA, | NA |
2687- | RES, | Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs |
- | Review, | NA, | NA | - | Review, | AD, | NA |
3612- | RES, | Resveratrol in Alzheimer's disease: a review of pathophysiology and therapeutic potential |
- | Review, | AD, | NA |
4286- | RES, | Neuroprotective Properties of Resveratrol and Its Derivatives—Influence on Potential Mechanisms Leading to the Development of Alzheimer’s Disease |
- | Review, | AD, | NA |
- | in-vivo, | IBD, | NA |
- | in-vitro, | Lung, | A549 |
3001- | RosA, | Therapeutic Potential of Rosmarinic Acid: A Comprehensive Review |
- | Review, | Var, | NA |
3003- | RosA, | Comprehensive Insights into Biological Roles of Rosmarinic Acid: Implications in Diabetes, Cancer and Neurodegenerative Diseases |
- | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Park, | NA |
3007- | RosA, | Hepatoprotective effects of rosmarinic acid: Insight into its mechanisms of action |
- | Review, | NA, | NA |
3036- | RosA, | Anti-Warburg effect of rosmarinic acid via miR-155 in colorectal carcinoma cells |
- | in-vitro, | CRC, | HCT8 | - | in-vitro, | CRC, | HCT116 | - | in-vitro, | CRC, | LS174T |
3934- | RT, | Rutin: A Potential Therapeutic Agent for Alzheimer Disease |
- | Review, | AD, | NA |
3936- | RT, | Rutin improves spatial memory in Alzheimer's disease transgenic mice by reducing Aβ oligomer level and attenuating oxidative stress and neuroinflammation |
- | in-vivo, | AD, | NA |
3663- | SFN, | Efficacy of Sulforaphane in Neurodegenerative Diseases |
- | Review, | AD, | NA | - | Review, | Park, | NA |
3658- | SFN, | Pre-Clinical Neuroprotective Evidences and Plausible Mechanisms of Sulforaphane in Alzheimer’s Disease |
- | Review, | AD, | NA |
3659- | SFN, | Epigenetic modification of Nrf2 by sulforaphane increases the antioxidative and anti-inflammatory capacity in a cellular model of Alzheimer's disease |
- | in-vitro, | AD, | NA |
1726- | SFN, | Sulforaphane: A Broccoli Bioactive Phytocompound with Cancer Preventive Potential |
- | Review, | Var, | NA |
1436- | SFN, | PacT, | docx, | Sulforaphane enhances the anticancer activity of taxanes against triple negative breast cancer by killing cancer stem cells |
- | in-vivo, | BC, | SUM159 |
1457- | SFN, | Sulforaphane Inhibits IL-1β-Induced IL-6 by Suppressing ROS Production, AP-1, and STAT3 in Colorectal Cancer HT-29 Cells |
- | in-vitro, | CRC, | HT-29 |
1508- | SFN, | Nrf2 targeting by sulforaphane: A potential therapy for cancer treatment |
- | Review, | Var, | NA |
3194- | SFN, | Sulforaphane impedes mitochondrial reprogramming and histone acetylation in polarizing M1 (LPS) macrophages |
- | in-vitro, | Nor, | NA |
3189- | SFN, | Sulforaphane Inhibits TNF-α-Induced Adhesion Molecule Expression Through the Rho A/ROCK/NF-κB Signaling Pathway |
- | in-vitro, | Nor, | ECV304 |
3187- | SFN, | Sulforaphane inhibits the expression of interleukin-6 and interleukin-8 induced in bronchial epithelial IB3-1 cells by exposure to the SARS-CoV-2 Spike protein |
- | in-vitro, | Nor, | IB3-1 |
3184- | SFN, | The Integrative Role of Sulforaphane in Preventing Inflammation, Oxidative Stress and Fatigue: A Review of a Potential Protective Phytochemical |
- | Review, | Nor, | NA |
3190- | SFN, | Sulforaphane inhibits TGF-β-induced fibrogenesis and inflammation in human Tenon’s fibroblasts |
- | in-vitro, | Nor, | NA |
3648- | SIL, | Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years |
- | Review, | NA, | NA |
4205- | SIL, | The Therapeutic Effect of Silymarin and Silibinin on Depression and Anxiety Disorders and Possible Mechanism in the Brain: A Systematic Review |
- | Review, | AD, | NA |
4206- | SIL, | Silymarin ameliorates experimentally induced depressive like behavior in rats: Involvement of hippocampal BDNF signaling, inflammatory cytokines and oxidative stress response |
- | in-vivo, | NA, | NA |
3301- | SIL, | Critical review of therapeutic potential of silymarin in cancer: A bioactive polyphenolic flavonoid |
- | Review, | Var, | NA |
3307- | SIL, | Flavolignans from Silymarin as Nrf2 Bioactivators and Their Therapeutic Applications |
- | Review, | Var, | NA |
3328- | SIL, | Modulatory effect of silymarin on inflammatory mediators in experimentally induced benign prostatic hyperplasia: emphasis on PTEN, HIF-1α, and NF-κB |
- | in-vivo, | BPH, | NA |
3323- | SIL, | Anticancer therapeutic potential of silibinin: current trends, scope and relevance |
- | Review, | Var, | NA |
3318- | SIL, | Pharmaceutical prospects of Silymarin for the treatment of neurological patients: an updated insight |
- | Review, | AD, | NA | - | Review, | Park, | NA |
2361- | SK, | Natural shikonin and acetyl-shikonin improve intestinal microbial and protein composition to alleviate colitis-associated colorectal cancer |
- | in-vivo, | CRC, | NA |
2218- | SK, | Shikonin Alleviates Endothelial Cell Injury Induced by ox-LDL via AMPK/Nrf2/HO-1 Signaling Pathway |
- | in-vitro, | Nor, | HUVECs |
2415- | SK, | Shikonin induces programmed death of fibroblast synovial cells in rheumatoid arthritis by inhibiting energy pathways |
- | in-vivo, | Arthritis, | NA |
3042- | SK, | The protective effects of Shikonin on lipopolysaccharide/D -galactosamine-induced acute liver injury via inhibiting MAPK and NF-kB and activating Nrf2/HO-1 signaling pathways |
- | in-vivo, | Nor, | NA |
3047- | SK, | Shikonin suppresses colon cancer cell growth and exerts synergistic effects by regulating ADAM17 and the IL-6/STAT3 signaling pathway |
- | in-vitro, | CRC, | HCT116 | - | in-vitro, | CRC, | SW48 |
1049- | SK, | Shikonin inhibits immune checkpoint PD-L1 expression on macrophage in sepsis by modulating PKM2 |
- | in-vivo, | NA, | NA |
2201- | SK, | Shikonin promotes ferroptosis in HaCaT cells through Nrf2 and alleviates imiquimod-induced psoriasis in mice |
- | in-vitro, | PSA, | HaCaT | - | in-vivo, | NA, | NA |
2213- | SK, | Shikonin attenuates cerebral ischemia/reperfusion injury via inhibiting NOD2/RIP2/NF-κB-mediated microglia polarization and neuroinflammation |
- | in-vivo, | Stroke, | NA |
1195- | SM, | Salvia miltiorrhiza polysaccharide activates T Lymphocytes of cancer patients through activation of TLRs mediated -MAPK and -NF-κB signaling pathways |
- | in-vitro, | Lung, | A549 | - | in-vitro, | Liver, | HepG2 | - | in-vitro, | CRC, | HCT116 |
3571- | TQ, | The Role of Thymoquinone in Inflammatory Response in Chronic Diseases |
- | Review, | Var, | NA | - | Review, | Stroke, | NA |
3559- | TQ, | Molecular signaling pathway targeted therapeutic potential of thymoquinone in Alzheimer’s disease |
- | Review, | AD, | NA | - | Review, | Var, | NA |
3427- | TQ, | Chemopreventive and Anticancer Effects of Thymoquinone: Cellular and Molecular Targets |
3422- | TQ, | Thymoquinone, as a Novel Therapeutic Candidate of Cancers |
- | Review, | Var, | NA |
3400- | TQ, | Chemo, | Thymoquinone Ameliorates Carfilzomib-Induced Renal Impairment by Modulating Oxidative Stress Markers, Inflammatory/Apoptotic Mediators, and Augmenting Nrf2 in Rats |
- | in-vitro, | Nor, | NA |
3404- | TQ, | The Neuroprotective Effects of Thymoquinone: A Review |
- | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Park, | NA | - | Review, | Stroke, | NA |
3410- | TQ, | Anti-inflammatory effects of thymoquinone and its protective effects against several diseases |
- | Review, | Arthritis, | NA |
2133- | TQ, | CUR, | Cisplatin, | Thymoquinone and curcumin combination protects cisplatin-induced kidney injury, nephrotoxicity by attenuating NFκB, KIM-1 and ameliorating Nrf2/HO-1 signalling |
- | in-vitro, | Nor, | HEK293 | - | in-vivo, | NA, | NA |
4037- | VitB12, | FA, | Mechanistic Link between Vitamin B12 and Alzheimer’s Disease |
- | Review, | AD, | NA |
4031- | VitB3, | Nicotinamide Riboside-The Current State of Research and Therapeutic Uses |
- | Review, | NA, | NA |
3111- | VitC, | https://pmc.ncbi.nlm.nih.gov/articles/PMC4492638/ |
- | Trial, | Nor, | NA |
3110- | VitC, | Vitamin C Attenuates Oxidative Stress, Inflammation, and Apoptosis Induced by Acute Hypoxia through the Nrf2/Keap1 Signaling Pathway in Gibel Carp (Carassius gibelio) |
- | in-vivo, | Nor, | NA |
3149- | VitC, | Hepatoprotective benefits of vitamin C against perfluorooctane sulfonate-induced liver damage in mice through suppressing inflammatory reaction and ER stress |
- | in-vivo, | Nor, | NA |
3128- | VitC, | Vitamin C Mitigates Oxidative Stress and Tumor Necrosis Factor-Alpha in Severe Community-Acquired Pneumonia and LPS-Induced Macrophages |
- | in-vitro, | Nor, | NA |
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:158 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid